Contribution of chondroitin sulfate a to the binding of complement proteins to activated platelets

PLoS ONE

Volumn 5, Issue 9, 2010, Pages

  Hamad, Osama A ^a   Nilsson, Per H ^b   Lasaosa, Maria ^c   Ricklin, Daniel ^c   Lambris, John D ^c   Nilsson, Bo ^a   Ekdahl, Kristina Nilsson ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b LINNAEUS UNIVERSITY   (Sweden)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN 4 SULFATE; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C4B BINDING PROTEIN; COMPLEMENT FACTOR H; MONOCLONAL ANTIBODY; SEPHAROSE; CHONDROITIN SULFATE; COMPLEMENT; SERPING1 PROTEIN, HUMAN;

ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BINDING SITE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE COMPLEX DISEASE; PROTEIN BINDING; PROTEIN CARBOHYDRATE INTERACTION; PROTEIN DEPLETION; THROMBOCYTE ACTIVATION; DRUG EFFECT; METABOLISM; THROMBOCYTE;

BLOOD PLATELETS; CHONDROITIN SULFATES; COMPLEMENT C1 INACTIVATOR PROTEINS; COMPLEMENT C1Q; COMPLEMENT C4B-BINDING PROTEIN; COMPLEMENT FACTOR H; COMPLEMENT SYSTEM PROTEINS; HUMANS; PLATELET ACTIVATION; PROTEIN BINDING;

EID: 77958525243     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012889     Document Type: Article

References (40)

1. Gandhi NS, Mancera RL (2008) The structure of glycosaminoglycans and their interactions with proteins. Chem Biol Drug Des 72: 455-482.
2. Lamari FN, Karamanos NK (2006) Structure of chondroitin sulfate. Adv Pharmacol 53: 33-48.
3. Sugahara K, Mikami T, Uyama T, Mizuguchi S, Nomura K, et al. (2003) Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate. Curr Opin Struct Biol 13: 612-620.
4. Taylor KR, Gallo RL (2006) Glycosaminoglycans and their proteoglycans: hostassociated molecular patterns for initiation and modulation of inflammation. Faseb J 20: 9-22.
5. Lamari FN, Theocharis AD, Asimakopoulou AP, Malavaki CJ, Karamanos NK (2006) Metabolism and biochemical/physiological roles of chondroitin sulfates: analysis of endogenous and supplemental chondroitin sulfates in blood circulation. Biomed Chromatogr 20: 539-550.
6. Malmstrom A, Aberg L (1982) Biosynthesis of dermatan sulphate. Assay and properties of the uronosyl C-5 epimerase. Biochem J 201: 489-493.
7. Sherman LS, Back SA (2008) A 'GAG' reflex prevents repair of the damaged CNS. Trends Neurosci 31: 44-52.
8. Okayama M, Oguri K, Fujiwara Y, Nakanishi H, Yonekura H, et al. (1986) Purification and characterization of human platelet proteoglycan. Biochem J 233: 73-81.
9. Ward JV, Packham MA (1979) Characterization of the sulfated glycosaminoglycan on the surface and in the storage granules of rabbit platelets. Biochim Biophys Acta 583: 196-207.
10. Donato JL, Nogueira MD, Marcondes S, Antunes E, Nader HB, et al. (1994) The kinetics of chondroitin 4-sulfate release from stimulated platelets and its relation to thromboxane A2 formation and granule secretion. Braz J Med Biol Res 27: 2163-2167.
11. MacPherson GG (1972) Synthesis and localization of sulphated mucopolysaccharide in megakaryocytes and platelets of the rat, an anlysis by electronmicroscope autoradiography. J Cell Sci 10: 705-717.
12. Woulfe DS, Lilliendahl JK, August S, Rauova L, Kowalska MA, et al. (2008) Serglycin proteoglycan deletion induces defects in platelet aggregation and thrombus formation in mice. Blood 111: 3458-3467.
13. Kishimoto TK, Viswanathan K, Ganguly T, Elankumaran S, Smith S, et al. (2008) Contaminated heparin associated with adverse clinical events and activation of the contact system. N Engl J Med 358: 2457-2467.
14. Hamad OA, Ekdahl KN, Nilsson PH, Andersson J, Magotti P, et al. (2008) Complement activation triggered by chondroitin sulfate released by thrombin receptor-activated platelets. J Thromb Haemost 6: 1413-1421.
15. Hamad OA, Nilsson PH, Wouters D, Lambris JD, Ekdahl KN, et al. Complement component C3 binds to activated normal platelets without preceding proteolytic activation and promotes binding to complement receptor 1. J Immunol 184: 2686-2692.
16. Anderluh M, Dolenc MS (2002) Thrombin receptor antagonists; recent advances in PAR-1 antagonist development. Curr Med Chem 9: 1229-1250.
17. Suzuki H, Packham MA, Kinlough-Rathbone RL (1995) Effects of thrombin and the thrombin receptor activating peptide, SFLLRN, on redistribution of platelet alpha-granule contents are similar and independent of the extent of thromboxane formation. Exp Mol Pathol 62: 63-72.
18. Peerschke EI, Ghebrehiwet B (1992) Platelet interactions with C1q in whole blood and in the presence of immune complexes or aggregated IgG. Clin Immunol Immunopathol 63: 45-50.
19. Peerschke EI, Ghebrehiwet B (1997) C1q augments platelet activation in response to aggregated Ig. J Immunol 159: 5594-5598.
20. Notkins AL (2004) Polyreactivity of antibody molecules. Trends Immunol 25: 174-179.
21. Tissot B, Gonnet F, Iborra A, Berthou C, Thielens N, et al. (2005) Mass spectrometry analysis of the oligomeric C1q protein reveals the B chain as the target of trypsin cleavage and interaction with fucoidan. Biochemistry 44: 2602-2609.
22. McGrath FD, Brouwer MC, Arlaud GJ, Daha MR, Hack CE, et al. (2006) Evidence that complement protein C1q interacts with C-reactive protein through its globular head region. J Immunol 176: 2950-2957.
23. Kishore U, Leigh LE, Eggleton P, Strong P, Perdikoulis MV, et al. (1998) Functional characterization of a recombinant form of the C-terminal, globular head region of the B-chain of human serum complement protein, C1q. Biochem J 333(Pt 1): 27-32.
24. Devine DV, Rosse WF (1987) Regulation of the activity of platelet-bound C3 convertase of the alternative pathway of complement by platelet factor H. Proc Natl Acad Sci U S A 84: 5873-5877.
25. Peerschke EI, Ghebrehiwet B (1994) Platelet membrane receptors for the complement component C1q. Semin Hematol 31: 320-328.
26. Vaziri-Sani F, Hellwage J, Zipfel PF, Sjoholm AG, Iancu R, et al. (2005) Factor H binds to washed human platelets. J Thromb Haemost 3: 154-162.
27. Deepa SS, Yamada S, Fukui S, Sugahara K (2007) Structural determination of novel sulfated octasaccharides isolated from chondroitin sulfate of shark cartilage and their application for characterizing monoclonal antibody epitopes. Glycobiology 17: 631-645.
28. Peerschke EI, Ghebrehiwet B (1987) Human blood platelets possess specific binding sites for C1q. J Immunol 138: 1537-1541.
29. Peerschke EI, Ghebrehiwet B (1988) Identification and partial characterization of human platelet C1q binding sites. J Immunol 141: 3505-3511.
30. Dahlback B, Frohm B, Nelsestuen G (1990) High affinity interaction between C4b-binding protein and vitamin K-dependent protein S in the presence of calcium. Suggestion of a third component in blood regulating the interaction. J Biol Chem 265: 16082-16087.
31. Mnjoyan Z, Li J, Afshar-Kharghan V (2008) Factor H binds to platelet integrin alphaIIbbeta3. Platelets 19: 512-519.
32. Lindahl TL, Larsson A (1993) C1q Binding to Platelets Induced by Monoclonal- Antibodies and Immune-Complexes - a Flow Cytometric Analysis. Platelets 4: 73-77.
33. Tenner AJ, Lesavre PH, Cooper NR (1981) Purification and radiolabeling of human C1q. J Immunol 127: 648-653.
34. Hammer CH, Wirtz GH, Renfer L, Gresham HD, Tack BF (1981) Large scale isolation of functionally active components of the human complement system. J Biol Chem 256: 3995-4006.
35. Nilsson UR, Mueller-Eberhard HJ (1965) Isolation of Beta If-Globulin from Human Serum and Its Characterization as the Fifth Component of Complement. J Exp Med 122: 277-298.
36. Sjoholm AG, Selander B, Ostenson S, Holmstrom E, Soderstrom C (1991) Normal human serum depleted of C1q, factor D and properdin: its use in studies of complement activation. Apmis 99: 1120-1128.
37. Henningsson AJ, Ernerudh J, Sandholm K, Carlsson SA, Granlund H, et al. (2007) Complement activation in Lyme neuroborreliosis-increased levels of C1q and C3a in cerebrospinal fluid indicate complement activation in the CNS. J Neuroimmunol 183: 200-207.
38. Myszka DG (1999) Improving biosensor analysis. J Mol Recognit 12: 279-284.
39. Myszka DG, Morton TA (1998) CLAMP: a biosensor kinetic data analysis program. Trends Biochem Sci 23: 149-150.
40. Morton TA, Myszka DG, Chaiken IM (1995) Interpreting complex binding kinetics from optical biosensors: a comparison of analysis by linearization, the integrated rate equation, and numerical integration. Anal Biochem 227: 176-185.